louisiana semaglutide gastroparesis law firm office glp-1 law office in louisiana Ozempic Lawsuit: May 2026 Blindness and Gastroparesis Claims-mvanhaasteren.nl Ozempic/Wegovy/Rybelsus Claims | ELG Law
Description
The risks have come into sharp focus during the present pandemic
The MHRA has approved a new 7.2mg dose of Wegovy three times higher than its highest currently approved dose for patients who require a higher percentage of weight loss.
Many people taking Ozempic and related drugs have reported mental health concerns
Some Canadian pharmacists are already stocking their shelves with generic versions of semaglutide, more commonly known by the brand name Ozempic
Though both payers had similar approval rates for anti-obesity GLP-1s in Medicare by Q2-2025, the paths to that point were unique to each payer
